Overview
US ultrasound device maker's Q1 revenue grew 25% yr/yr, beating analyst expectations
Revenue growth driven by Embedded partnerships and higher-priced product sales mix
Outlook
Butterfly Network reaffirms 2026 revenue guidance of $117 mln to $121 mln
Company expects 2026 adjusted EBITDA loss of $21 mln to $25 mln
Butterfly Network sees Q2 revenue between $27 mln and $31 mln
Result Drivers
EMBEDDED PARTNERSHIPS - U.S. revenue growth was mainly driven by Butterfly Embedded partnerships, including co-development with Midjourney
PRODUCT MIX - Both U.S. and international revenue benefited from a shift toward higher-priced iQ3 probes
LICENSING REVENUE AND COST REDUCTION - Gross margin improvement was attributed to higher-margin Embedded licensing revenue and lower software amortization costs
Company press release: ID:nBw7WkGsha
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$26.50 mln
$26.07 mln (4 Analysts)
Q1 Adjusted EPS
Beat
-$0.03
-$0.07 (4 Analysts)
Q1 Net Income
-$12.70 mln
Q1 Adjusted EBITDA
-$6.10 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Butterfly Network Inc is $5.50, about 11.8% above its April 29 closing price of $4.92
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)